Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Sep 1;5(5):521-528.
doi: 10.2217/17410541.5.5.521.

US system of oversight for genetic testing: a report from the Secretary's Advisory Committee on Genetics, Health and Society

Andrea Ferreira-Gonzalez  1 , Steven Teutsch, Marc S Williams, Sylvia M Au, Kevin T Fitzgerald, Paul Steven Miller, Cathy Fomous
Affiliations

US system of oversight for genetic testing: a report from the Secretary's Advisory Committee on Genetics, Health and Society

Andrea Ferreira-Gonzalez et al. Per Med. .

Abstract

As genetic testing technology is integrated into healthcare, increasingly detailed information about individual and population genetic variation is available to patients and providers. Health professionals use genetic testing to diagnose or assess the risk of disease in individuals, families and populations and to guide healthcare decisions. Consumers are beginning to explore personalized genomic services in an effort to learn more about their risk for common diseases. Scientific and technological advances in genetic testing, as with any newly introduced medical technology, present certain challenges to existing frameworks of oversight. In addition, the growing use of genetic testing will require a significant investment in evidence-based assessments to understand the validity and utility of these tests in clinical and personal decisionmaking. To optimize the use of genetic testing in healthcare, all sectors of the oversight system need to be strengthened and yet remain flexible in order to adapt to advances that will inevitably increase the range of genetic tests and methodologies.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

Bibliography

    1. Katsanis SH, Javitt G, Hudson K. A case study of personalized medicine. Science. 2008;320(5872):53–54. - PubMed
    1. Balas EA. Information systems can prevent errors and improve quality. J. Am. Med. Inform. Assoc. 2001;8:398–399. - PMC - PubMed
    1. Alvarez R. The electronic health record: a leap forward in patient safety. Healthcare Papers. 2004;5:33–36. - PubMed
    1. Employee Retirement Income Security Act of 1974 (ERISA), Pub. L. No. 93-406, 88 Stat. 829 (1974) (codified at 29 U.S.C. §1001 et seq.). See, e.g., ERISA §§ 514(a), (b)(2)(A), and (b)(2)(B) at 29 U.S.C. §§ 1144(a), (b)(2)(A), and (b)(2)(B) which can have the effect of preempting State tort lawsuits against ERISA health insurance plans for alleged misuses of genetic information in medical necessity determinations.
    1. Health Insurance Portability and Accountability Act of 1996 (HIPAA), Pub. L. No. 104-191, 110 Stat. 1936 (1996) (codified at scattered sections of the U.S. Code). See also, HIPAA privacy regulations at 45 C.F.R. Parts 160, 164, which set forth medical privacy rules affecting use and disclosure of genetic information by HIPAA-covered entities.

Websites

    1. Department of Health and Human Services. Personalized Health Care: Goals. [Accessed on April 1, 2008]. www.dhhs.gov/myhealth care/goals/index.html#Goal3.
    1. Secretary’s Advisory Committee on Genetics, Health, and Society. [Accessed on April 1, 2008]. www4.od.nih.gov/oba/sacghs.htm.
    1. Secretary’s Advisory Committee on Genetics, Health, and Society. US system of oversight of genetic testing: a response to the charge of the secretary of HHS. See p. iii-v. [Accessed on May 1, 2008]. www4.od.nih.gov/oba/sacghs/reports/SAC GHS_oversight_report.pdf. - PMC - PubMed

    1. Secretary’s Advisory Committee on Genetics, Health, and Society. US system of oversight of genetic testing: a response to the charge of the secretary of HHS. [Accessed on May 1, 2008]. www4.od.nih.gov/oba/sacghs/reports/SACGHS_oversight_report.pdf.•• Full oversight report of the Committee

    1. US FDA: Center for Devices and Radiological Health. [Accessed on April 23, 2008]. www.fda.gov/cdrh/ - PubMed